Decellularized Muscle Supports New Muscle Fibers and Improves Function Following Volumetric Injury
Enhanced Regeneration Observed in Large Volumetric Muscle Defects
What the Top 10 Biopharma CEOs Are Making
Surging Markets Drive Double- and Triple-Digit Percentage Gains for Compensation
Exosomes from Cancer Cells Could Predict Immunotherapy Responses
Immune-Evasion Mechanism May Help Explain the Differences in Responses to Immunotherapy
The Scoop: Tissue Engineering Covers Wide Range of Applications
3D Approach Aims to Replace Human Tissue and Organs
For full access to this article login to GEN Select now.
What Is the Real Drug Development Cost for Very Small Biotech Companies?
A small biotech company, virtual or not, has nowhere near $2 billion to bring a drug to market. A simple calculation shows that it can be done for less than $250 million.
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.